[HTML][HTML] Role of Selenium in Pathogenesis and Treatment of the Autoimmune Diseases

E Rahmani, AM Fard, H Baghsheikhi, Z Hosseini… - Kindle, 2022 - preferpub.org
In vitro investigations have revealed that consumption of selenium can considerably
decrease the expression of IFN-g in Th1 cells. A low plasma selenium content has been …

[HTML][HTML] Frontiers in sarcopenia: Advancements in diagnostics, molecular mechanisms, and therapeutic strategies

D Liu, S Wang, S Liu, Q Wang, X Che, G Wu - Molecular Aspects of …, 2024 - Elsevier
The onset of sarcopenia is intimately linked with aging, posing significant implications not
only for individual patient quality of life but also for the broader societal healthcare …

Drug‐related sarcopenia as a secondary sarcopenia

M Kuzuya - Geriatrics & Gerontology International, 2024 - Wiley Online Library
Sarcopenia has a significant impact on falls, physical function, activities of daily living, and
quality of life in older adults, and its prevention and treatment are becoming increasingly …

Sarcopenia and Nutrition in Elderly Rheumatoid Arthritis Patients: A Cross-Sectional Study to Determine Prevalence and Risk Factors

L Cano-García, S Manrique-Arija… - Nutrients, 2023 - mdpi.com
Objective: To describe the prevalence of sarcopenia in rheumatoid arthritis (RA) patients
aged≥ 65 years and identify the risk factors associated with sarcopenia. Methods: This is a …

Spondyloarthritis and sarcopenia: prevalence of probable sarcopenia and its impact on disease burden: the Saspar Study

B Merle, M Cottard, E Sornay-Rendu, P Szulc… - Calcified Tissue …, 2023 - Springer
To evaluate the prevalence of probable, confirmed, and severe sarcopenia in
spondyloarthritis (SpA), according to the European Working Group on Sarcopenia in Older …

Inflammatory profile in patients with rheumatoid arthritis and sarcopenia

M Lozada-Mellado, L Llorente, A Hinojosa-Azaola… - Clinical …, 2024 - Springer
Introduction Sarcopenia is characterized by the loss of muscle mass and strength associated
with aging; however, individuals with chronic diseases are at risk at the early stages. In …

Adipokines in Rheumatoid Arthritis: Emerging Biomarkers and Therapeutic Targets

J Bilski, A Schramm-Luc, M Szczepanik, AI Mazur-Biały… - Biomedicines, 2023 - mdpi.com
Rheumatoid arthritis (RA) is a chronic inflammatory disease manifested by joint involvement,
extra-articular manifestations, and general symptoms. Adipose tissue, previously perceived …

Is sarcopenia a real concern in ankylosing spondylitis? A systematic literature review

C Ceolin, MV Papa, L Scagnellato, A Doria… - European Geriatric …, 2024 - Springer
Purpose Sarcopenia is a condition defined as loss of muscle mass and strength, associated
with poor functional performance and disability. Sarcopenia can be exacerbated or …

Häufigkeit und Schweregrad von Sarkopenie bei Patient* innen mit entzündlichen und nichtentzündlichen muskuloskeletalen Erkrankungen

B Buehring, C Mueller, R Parvaee, I Andreica… - Zeitschrift für …, 2023 - Springer
Zusammenfassung Einleitung Als Sarkopenie (SP) bezeichnet man den pathologischen
Verlust an Muskelmasse und-funktion. Dies stellt va bei geriatrischen Patient* Innen ein …

Age, body mass index, and function as the independent predictors of sarcopenia in axial spondyloarthritis: a cross-sectional analysis

N Kanjanavaikoon, P Saisirivechakun… - Clinical …, 2023 - Springer
Background/objective Sarcopenia is characterized by a decline in muscle strength, muscle
mass, and physical performance. Persistent inflammation may lead to muscle wasting. This …